| Dr Lori Ann Eason, OD | |
|
3702 I-40 East, Amarillo, TX 79103 | |
| (806) 379-9090 | |
| (806) 379-9091 |
| Full Name | Dr Lori Ann Eason |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 3702 I-40 East, Amarillo, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104923283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4984T (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lori Ann Eason, OD 16327 Prairie Garden, Canyon, TX 79015 Ph: (806) 379-9090 | Dr Lori Ann Eason, OD 3702 I-40 East, Amarillo, TX 79103 Ph: (806) 379-9090 |
News Archive
COVID-19 can have damaging effects on multiple organs in the body, including the brain. A new study led by investigators at Massachusetts General Hospital (MGH) and Beth Israel Deaconess Medical Center (BIDMC) indicates that some hospitalized patients with COVID-19 experience non-convulsive seizures, which may put them at a higher risk of dying. The findings are published in the Annals of Neurology.
The U.S. Food and Drug Administration today announced plans to hold an advisory panel on Dec. 14-15, 2010, to discuss several scientific issues that may affect the regulation of dental amalgam, used for direct filling of carious lesions or structural defects in teeth. The panel meeting will focus particularly on the potential risk to vulnerable populations, such as pregnant women, fetuses, and young children.
Ensuring that patients are loyal toward targeted online services comes down to whether they perceive the service to be useful and that the service is easy to use, report Spanish researchers.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Atazanavir Sulfate Capsules, 150 mg and 300 mg. This product will be eligible for purchase outside the U.S. in certain developing countries.
› Verified 3 days ago
Julia Fitzpatrick, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-355-9703 | |
Charlie Jim Moore, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2481 I 40 W, Amarillo, TX 79109 Phone: 806-358-2205 Fax: 806-463-2907 | |
William A Sansing, OPTOMETRIST Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2700 Paramount Blvd, Amarillo, TX 79109 Phone: 806-355-9536 Fax: 806-353-5572 | |
Dr. Candace E Lipshy, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5311 W 9th Ave, Amarillo, TX 79106 Phone: 806-359-3937 Fax: 806-359-8124 | |
Dr. William Robert Chafin Iii, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2303 S Georgia St, Amarillo, TX 79109 Phone: 806-359-3956 Fax: 806-355-6907 | |
Kayci Houlette, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3635 S Soncy Rd, Amarillo, TX 79119 Phone: 806-356-6868 Fax: 806-351-0120 | |
Medical Center Eye Associates, P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 1900 S Coulter Drive, Suite I, Amarillo, TX 79106 Phone: 806-355-9411 Fax: 806-322-3451 |